Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average (2016 - 2025)

Agios Pharmaceuticals' Assets Average history spans 13 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 22.35% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 22.35%, while the annual FY2025 figure was $1.5 billion, 13.85% up from the prior year.
  • Assets Average reached $1.3 billion in Q4 2025 per AGIO's latest filing, down from $1.4 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $2.2 billion in Q2 2021 to a low of $811.4 million in Q2 2024.
  • Average Assets Average over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2022.
  • Peak YoY movement for Assets Average: soared 145.68% in 2021, then crashed 40.68% in 2022.
  • A 5-year view of Assets Average shows it stood at $1.5 billion in 2021, then fell by 18.8% to $1.2 billion in 2022, then fell by 19.62% to $972.2 million in 2023, then surged by 77.69% to $1.7 billion in 2024, then dropped by 22.35% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Assets Average are $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.5 billion (Q2 2025).